Saturday 17 October 2026 Export PBYI’s income statement to Excel — free account

Puma Biotechnology, Inc.

Puma Biotechnology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $228.4 million, down 0.91% from fiscal 2024. In the quarter to June 2026, revenue grew 7.75%, EPS grew 33.3%, free cash flow fell 88.5% and total debt fell 79.8%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

9.83 0.69 −6.56%

Follow PBYI

Alert me

Market cap: $543.0M
P/E: 18.2×
Fwd P/E: 24.2×
Dividend yield: —
F-score: 8/9
Altman Z: −4.16
Beneish M: −2.06
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	15.02	12.78	9.44	7.08	+8 more quarters Free account
P/S ratio Full definition →	1.79	1.43	1.30	1.26
P/FCF ratio Full definition →	14.46	7.92	10.18	8.80
P/Operating CF Full definition →	254.39	21.08	20.64	27.59
P/B ratio Full definition →	2.98	2.53	2.28	2.32
Price to Tangible BV Full definition →	4.05	3.63	3.35	3.74
EV/Sales Full definition →	1.48	1.07	1.01	1.02
EV/EBITDA Full definition →	8.34	6.05	4.80	4.82
EV/Operating CF Full definition →	8.30	4.54	5.53	5.01
EV/FCF Full definition →	11.95	5.93	7.91	7.09
Quick Ratio Full definition →	2.57	2.18	1.89	1.57
Current Ratio Full definition →	2.91	2.38	2.00	1.74
Net Debt/EBITDA Full definition →	(9.30)	74.24	(3.90)	(5.10)
Debt/Assets Full definition →	0.00%	5.86%	10.41%	16.62%
Debt/Equity Full definition →	0.00	0.09	0.17	0.29
Asset Turnover Full definition →	1.19	1.17	1.06	1.00
Operating CF/Net income Full definition →	0.20	(4.11)	1.07	1.10
Capex/Depreciation Full definition →	0.00	0.00	0.01	(0.01)
Interest Coverage Full definition →	42.14	(5.24)	15.29	6.43
Research and Development Expense of Revenue Full definition →	33.44%	44.17%	22.32%	29.21%
Selling, General and Administrative Expense of Revenue Full definition →	31.06%	41.11%	24.36%	30.87%
Intangible Assets out of Total Assets Full definition →	0.19	0.20	0.19	0.22
Share Based Compensation of Revenue Full definition →	3.46%	4.23%	2.14%	3.07%
Graham Net Nets Full definition →	0.22	0.24	0.26	0.21
Graham Number Full definition →	5.75	5.33	6.08	6.22
Earnings Yield Full definition →	6.66%	7.82%	10.59%	14.12%
Free Cash Flow Yield Full definition →	6.92%	12.63%	9.82%	11.36%
Revenue per Share Full definition →	1.11	0.88	1.51	1.08
Operating CF per Share Full definition →	0.03	0.30	0.29	0.19
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	0.03	0.30	0.29	0.19
Cash per Share Full definition →	1.84	2.04	1.99	1.92
Shareholders Equity per Share Full definition →	2.72	2.53	2.61	2.29
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	2.72	2.53	2.61	2.29
Free Cash Flow Full definition →	1.62	15.42	14.46	9.66
Working Capital Full definition →	95.25	82.52	81.43	60.85
Capital Expenditures Full definition →	—	—	0.04	(0.03)
Net Current Asset Value Full definition →	90.88	77.98	76.72	55.99
EV/EBIT Full definition →	11.22	8.26	6.20	6.42
Capex to Sales Full definition →	0.00	0.00	0.00	0.00
Price to Operating Income Full definition →	13.57	11.02	7.98	7.97
Other line items
Average Receivables Full definition →	29.99	25.75	42.83	44.10
Average Payables Full definition →	4.26	7.10	5.28	6.95
Average Inventory Full definition →	10.96	8.72	7.12	6.07
Average Assets Full definition →	193.83	194.44	214.82	211.79
Average Common Equity Full definition →	121.63	112.76	111.23	93.18

Fold the line items

Columns are period end dates

Stockrow Weekly